Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

XPH vs PJP: Which Pharma ETF Offers Better Value

State Street's lower costs appeal to buy-and-hold investors, while Invesco's concentrated portfolio and lower volatility suit risk-averse income seekers.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at fool.com →

More in Finance & Markets

More from Monday 17 August →